This website is for UK Healthcare Professionals only

ASH 2022 - The 64th American Society of Haematology Annual Meeting and Exposition

About the latest data for VENCLYXTO® in Acute Myloid Leukaemia (AML)

To receive the latest AbbVie information on upcoming congresses

On demand: Access content from ASH 2022

Dr Priyanka Mehta

Dr Mehta discusses the long-term follow-up of VIALE-A trial

Professor Charlie Craddock

Professor Craddock discusses ELN risk stratification and outcomes with venetoclax and azacitidine


Adverse events should be reported. Reporting forms and information can be found at

Adverse events should also be reported to AbbVie on [email protected]

UK-VNCAML-220255. Date of Preparation: February 2023.